2023-2024 Regular Session • Delaware Legislature

HB16: An Act To Amend Titles 29 And 31 Of The Delaware Code Relating To Ovarian Cancer.

Legislative Summary

This Act requires that Medicaid and State employee health plans cover: (1) ovarian cancer monitoring tests for women treated for ovarian cancer; and (2) annual screening tests for women at risk for ovarian cancer.

Bill History

2/29/2024

Introduced and Assigned to Health & Human Development Committee in House

3/13/2024

Reported Out of Committee (Health & Human Development) in House with 10 Favorable, 2 On Its Merits

3/19/2024

Assigned to Appropriations Committee in House

5/21/2024

Amendment HA 1 to HB 16 - Introduced and Placed With Bill

5/22/2024

Reported Out of Committee (Appropriations) in House with 1 Favorable, 5 On Its Merits

6/11/2024

Amendment HA 1 to HB 16 - Passed In House by Voice Vote

6/11/2024

Passed By House. Votes: 39 YES 2 ABSENT

6/11/2024

Assigned to Health & Social Services Committee in Senate

6/18/2024

Reported Out of Committee (Health & Social Services) in Senate with 5 On Its Merits

6/18/2024

Assigned to Finance Committee in Senate

6/26/2024

Reported Out of Committee (Finance) in Senate with 4 On Its Merits

6/30/2024

Passed By Senate. Votes: 21 YES

10/9/2024

Signed by Governor

Roll Call Votes

Senate Third Reading

6/30/2024

Yea

Nay

Not Voting

Absent

Result: PASSED

House Third Reading

6/11/2024

Yea

Nay

Not Voting

Absent

Result: PASSED

Status Information

Current Status

Passed(10/9/2024)

Chamber

House of Representatives

Sine DiePrior Session

HB16: An Act To Amend Titles 29 And 31 Of The Delaware Code Relating To Ovarian Cancer.

Legislative Summary

Bill History

Roll Call Votes

Status Information

Sponsors

Primary Sponsor

Co-Sponsors (22)

Documents

External Links